Helix BioPharma receives regulatory approval to dose patients in phase II study of L-DOS47 April 11, 2018
Afinitor Disperz receives FDA approval for the treatment of TSC-associated partial-onset seizures April 11, 2018
First patient dosed in global phase II study of tislelizumab in previously treated HCC April 11, 2018
Alexion Pharmaceuticals makes recommended public cash offer to acquire Wilson Therapeutics April 11, 2018
RSS